Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sabra Health Care REIT
(NASDAQ:SBRA)
Intraday
$14.16
0.22
[1.58%]
After-Hours
$13.94
-0.2200
[-1.55%]
Get Report
Watch
Perks
Buy
Compare Brokers
$14.16
0.22
[1.58%]
At close: Apr 29
$13.94
-0.2200
[-1.55%]
After Hours: 4:20PM EDT
Get Report
Watch
Q1 2024 Earnings in 9 days from now on Wed May 8th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Sabra Health Care REIT Stock (NASDAQ:SBRA)
Sabra Health Care REIT Stock (NASDAQ: SBRA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, March 26, 2024
Deere, ASML, Steel Dynamics And A Real Estate Stock: CNBC's 'Final Trades'
Avi Kapoor
-
Mar 26, 2024, 8:25AM
Monday, March 25, 2024
CNBC Halftime Report Final Trades: Steel Dynamics, Sabra Health Care REIT, ASML Holding, Deere & Company
Benzinga Newsdesk
-
Mar 25, 2024, 1:00PM
Tuesday, February 27, 2024
Sabra Health Care REIT Sees FY24 Normalized AFFO $1.39-$1.43 Vs $1.38 Est.
Benzinga Newsdesk
-
Feb 27, 2024, 4:46PM
Sabra Health Care REIT Q4 2023 GAAP EPS $0.33, Inline, Sales $163.40M Beat $158.10M Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 4:38PM
Sabra Health Care REIT Q4 Sales $163.40M Beat $158.10M Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 4:14PM
Earnings Scheduled For February 27, 2024
Benzinga Insights
-
Feb 27, 2024, 5:01AM
Friday, February 16, 2024
Healthcare REITs Showing Strong Performance In February
Ethan Roberts
-
Feb 16, 2024, 6:45AM
Wednesday, February 07, 2024
Friday Is Your Last Chance To Buy Sabra Health Care REIT Before The Dividend Payout
Benzinga Insights
-
Feb 7, 2024, 9:45AM
Sunday, February 04, 2024
Analyst Initiates Coverage On 10 Healthcare REITs, But Which Ones Are Buys?
Ethan Roberts
-
Feb 4, 2024, 7:56AM
Wednesday, January 31, 2024
Nucor, Sabra Health Care And A Major Investment Bank: CNBC's 'Final Trades'
Avi Kapoor
-
Jan 31, 2024, 8:12AM
Tuesday, January 30, 2024
Deutsche Bank Initiates Coverage On Sabra Health Care REIT with Buy Rating, Announces Price Target of $21
Benzinga Newsdesk
-
Jan 30, 2024, 7:05AM
Wednesday, January 03, 2024
Analyst Ratings For Sabra Health Care REIT
Benzinga Insights
-
Jan 3, 2024, 1:00PM
Mizuho Maintains Buy on Sabra Health Care REIT, Raises Price Target to $17
Benzinga Newsdesk
-
Jan 3, 2024, 10:35AM
Tuesday, November 21, 2023
Invitation Homes, Tradeweb Markets, Sabra Health Care And More On CNBC's 'Final Trades'
Lisa Levin
-
Nov 21, 2023, 10:05AM
Monday, November 20, 2023
CNBC Halftime Report Final Trades: Invitation Homes, Sabra Health Care REIT
Benzinga Newsdesk
-
Nov 20, 2023, 1:02PM
Tuesday, November 07, 2023
Analyst Ratings for Sabra Health Care REIT
Benzinga Insights
-
Nov 7, 2023, 4:00PM
Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16
Benzinga Newsdesk
-
Nov 7, 2023, 10:10AM
Monday, November 06, 2023
Sabra Health Care REIT Q3 FFO EPS $0.33 Down From $0.36 YoY, Sales $161.63M Beat $158.95M Estimate
Benzinga Newsdesk
-
Nov 6, 2023, 4:20PM
Earnings Scheduled For November 6, 2023
Benzinga Insights
-
Nov 6, 2023, 8:24AM
Friday, November 03, 2023
Sabra Health Care REIT's Earnings Outlook
Benzinga Insights
-
Nov 3, 2023, 11:00AM
Friday, October 20, 2023
3 REITs That Were Hit With Downgrades This Week
Ethan Roberts
-
Oct 20, 2023, 12:15PM
Tuesday, October 17, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
Benzinga Insights
-
Oct 17, 2023, 11:00AM
Wells Fargo Maintains Equal-Weight on Sabra Health Care REIT, Raises Price Target to $15
Benzinga Newsdesk
-
Oct 17, 2023, 9:58AM
BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target
Benzinga Newsdesk
-
Oct 17, 2023, 7:19AM
Monday, October 16, 2023
Analysts Just Upgraded These Three Healthcare REITs
Ethan Roberts
-
Oct 16, 2023, 4:25PM
Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023
Benzinga Insights
-
Oct 16, 2023, 11:00AM
Wells Fargo Upgrades Sabra Health Care REIT to Equal-Weight, Announces $15 Price Target
Benzinga Newsdesk
-
Oct 16, 2023, 6:33AM
Tuesday, October 10, 2023
Analyst Ratings for Sabra Health Care REIT
Benzinga Insights
-
Oct 10, 2023, 5:00PM
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Benzinga Insights
-
Oct 10, 2023, 11:00AM
B of A Securities Upgrades Sabra Health Care REIT to Buy
Benzinga Newsdesk
-
Oct 10, 2023, 7:36AM
Tuesday, October 03, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023
Benzinga Insights
-
Oct 3, 2023, 11:00AM
Wedbush Initiates Coverage On Sabra Health Care REIT with Outperform Rating, Announces Price Target of $16
Benzinga Newsdesk
-
Oct 3, 2023, 8:01AM
Friday, September 29, 2023
The 3 Best-Performing REITs In September
Ethan Roberts
-
Sep 29, 2023, 1:05PM
Tuesday, September 26, 2023
Top 2 Real Estate Stocks That Are Ticking Portfolio Bombs
Lisa Levin
-
Sep 26, 2023, 7:12AM
Friday, September 22, 2023
Analysts: Healthcare REITs Show A Dichotomy Of Performance
Ethan Roberts
-
Sep 22, 2023, 1:37PM
Wednesday, September 20, 2023
Where Sabra Health Care REIT Stands With Analysts
Benzinga Insights
-
Sep 20, 2023, 5:00PM
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
Benzinga Insights
-
Sep 20, 2023, 11:00AM
Jefferies Upgrades Sabra Health Care REIT to Buy, Raises Price Target to $15
Benzinga Newsdesk
-
Sep 20, 2023, 5:54AM
Thursday, August 31, 2023
Sabra Health Care REIT Updates Shareholder Engagement Strategy to Reflect Changing Business Conditions
Benzinga Insights
-
Aug 31, 2023, 11:05AM
Thursday, August 17, 2023
Live On CNBC, Jenny Harrington Announces Bought More Sabra Health Care REIT, B&G Foods
Happy Mohamed
-
Aug 17, 2023, 12:50PM
Wednesday, August 16, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Real Estate Stocks With Over 9% Dividend Yields
Lisa Levin
-
Aug 16, 2023, 8:56AM
Friday, August 11, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Benzinga Insights
-
Aug 11, 2023, 11:00AM
Tuesday Is Your Last Chance To Buy Sabra Health Care REIT Before The Dividend Payout
Benzinga Insights
-
Aug 11, 2023, 10:45AM
B of A Securities Upgrades Sabra Health Care REIT to Neutral, Raises Price Target to $14
Benzinga Newsdesk
-
Aug 11, 2023, 9:15AM
Monday, August 07, 2023
Sabra Health Care REIT Q2 FFO $0.33 Down From $0.39 YoY, Sales $161.17M Miss $163.17M Estimate
Benzinga Newsdesk
-
Aug 7, 2023, 4:21PM
Earnings Scheduled For August 7, 2023
Benzinga Insights
-
Aug 7, 2023, 4:12AM
Thursday, July 27, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Benzinga Insights
-
Jul 27, 2023, 11:00AM
Berenberg Initiates Coverage On Sabra Health Care REIT with Hold Rating, Announces Price Target of $13
Benzinga Newsdesk
-
Jul 27, 2023, 6:44AM
Tuesday, July 18, 2023
Check Out 3 High-Yielding Dividend Stocks In Real Estate Sector From Wall Street's Most Accurate Analysts
Lisa Levin
-
Jul 18, 2023, 8:39AM
Friday, July 14, 2023
Expert Ratings for Sabra Health Care REIT
Benzinga Insights
-
Jul 14, 2023, 1:00PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch